It seems everyone who tries this - patient and surgeon - is satisfied. Continued strong data. Will continue to penetrate the breast reconstruction market leaving saline expanders obsolete and encouraging implant vs reconstruction.
Agree that FDA approval likely to see further jump in SP. Once they have approval and established production in Costa Rica we will see big US marketing and training (of surgeons) push. I am sure a CR will come at that point. Then just sit back and watch sales grow. This is as solid as it gets for a bio-medical company.
Tyremen
Ann: Positive Results Highlighted at ASPS Annual Meeting-AXP.AX, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.684M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 29583410 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 59394450 | 39 |
View Market Depth
| Last trade - 16.13pm 20/06/2025 (20 minute delay) ? |
| AXP (ASX) Chart |
Day chart unavailable